HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

--A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor EWS.

Abstract
Aberrant expression of the transcription factor ERG is a key driving event in approximately one-half of all of prostate cancers. Lacking an enzymatic pocket and mainly disordered, the structure of ERG is difficult to exploit for therapeutic design. We recently identified EWS as a specific interacting partner of ERG that is required for oncogenic function. In this study, we aimed to target this specific protein-protein interaction with small molecules. A high-throughput screening (HTS) strategy was implemented to identify potential protein-protein interaction inhibitors. Secondary assays verified the function of several hit compounds, and one lead compound inhibited ERG-mediated phenotypes in prostate cells. This is the first study aimed at targeting the ERG-EWS protein-protein interaction for the development of a small molecule-based prostate cancer therapy.
AuthorsTaylor R Nicholas, Jingwei Meng, Benjamin M Greulich, Teresa Stevie Morris, Peter C Hollenhorst
JournalPloS one (PLoS One) Vol. 15 Issue 9 Pg. e0238999 ( 2020) ISSN: 1932-6203 [Electronic] United States
PMID32915889 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ERG protein, human
  • EWSR1 protein, human
  • RNA-Binding Protein EWS
  • Recombinant Proteins
  • Small Molecule Libraries
  • Transcriptional Regulator ERG
Topics
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor (methods)
  • Feasibility Studies
  • High-Throughput Screening Assays (methods)
  • Humans
  • Male
  • Prostatic Neoplasms (drug therapy, genetics, metabolism)
  • Protein Interaction Domains and Motifs (drug effects)
  • RNA-Binding Protein EWS (antagonists & inhibitors, genetics, metabolism)
  • Recombinant Proteins (drug effects, genetics, metabolism)
  • Small Molecule Libraries
  • Transcriptional Regulator ERG (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: